Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 and certain immune cells are linked to more severe alopecia areata.

Certain genetic variants in ERN1, TACR3, and SPPL2C are linked to when Alzheimer's disease starts.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Targeting PTEN can improve healing in venous leg ulcers.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Activating TLR3 helps improve skin and hair follicle regeneration after wounds.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

A new 3-D bioreactor system improves drug screening and reduces animal testing.

A two-step method was created in 2015 to make more cells that help with hair growth, but they need to be combined with other cells for 4 days to actually form new hair.

Decomposed tritiated thymidine is less accurate for DNA tracing, and hair changes can indicate malnutrition.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

The proteins transthyretin and megalin are more present in the growth phase of hair, suggesting they might affect hair health and growth.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Increasing mir-302 turns human hair cells into stem cells by changing gene regulation and demethylation.

Using enzymes to break down scalp hair follicles gets more stem cells for skin and hair growth than the old method.

Adult skin cell-based early-stage skin substitutes improve wound healing and hair growth in mice.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Blocking mTORC1 activity could increase hair pigmentation and potentially reverse greying.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Thread-embedding therapy helped hair grow back in mice and might do the same in humans.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

3D cultivation and prenatal stem cell exosomes improve stem cell treatment results, especially for hair loss and age-related issues.

Exosome-enriched vesicles from placental cells improved skin condition in a patient with chronic graft-versus-host disease.